ENTITY
Mega Lifesciences

Mega Lifesciences (MEGA TB)

70
Analysis
Health Care • Thailand
Mega Lifesciences PCL manufactures, markets and distributes nutritional and herbal supplement, OTC and ethical drugs. The Company produces products that range from treating internal issues to overall general health.
more
•05 Aug 2022 07:35•Broker

Big Cap Tactical Picks - August 4, 2022

Yesterday, our Big Cap portfolio generated a return of +0.33% vs. the SET Index’s return of +0.35%. The share prices of stocks under the reopening...

Logo
217 Views
Share
•04 Aug 2022 08:12•Broker

Monthly Report - August 2022

We expect the SET Index to move up, with the support at 1,555/1,530 points and the resistance at 1,600/1,616 points, on the back of foreign...

Logo
298 Views
Share
•04 Aug 2022 07:51•Broker

Big Cap Tactical Picks - Aug 3, 2022

MEGA’s share price has rebounded by more than 5% over the past two weeks on the market’s expectations for a limited impact from Myanmar’s government

Logo
251 Views
Share
bullish•Mega Lifesciences
•05 Jan 2022 10:33•Broker

MEGA: Expect Growth Rate to Slow Down in 2022

We maintain BUY rating and roll over target price to Bt56 (+8% from previous TP) based on 25xPE’22E, a 15% discount from Thai health care peers.

bullish•Mega Lifesciences
•19 Nov 2018 14:44•Broker

MEGA: 3Q18 Result Is Slightly Below Our Expectation

MEGA reported 3Q18 net profit of Bt255m (+4%YoY, -12%QoQ). 9M18 result accounts for 63% of our full year forecast and is slightly below our...

x